Exercise training increases interleukin-10 after an acute myocardial infarction: A randomised clinical trial

International Journal of Sports Medicine

Volumn 33, Issue 3, 2012, Pages 192-198

  Ribeiro, F ^a,b   Alves, A J ^a   Teixeira, M ^c   Miranda, F ^c   Azevedo, C ^c   Duarte, J A ^a   Oliveira, J ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b CESPU   (Portugal)

^c CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

Author keywords

coronary artery disease; endothelial function; inflammation; rehabilitation

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84857786419     PISSN: 01724622     EISSN: 14393964     Source Type: Journal    
DOI: 10.1055/s-0031-1297959     Document Type: Article

References (31)

1. th ed. Philadelphia, PA Lippincott Williams & Wilkins: 2005
2. Adamopoulos S, Parissis J, Kroupis C, Georgiadis M, Karatzas D, Karavolias G, Koniavitou K, Coats A J, Kremastinos D T. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J: 2001; 22 791 797 (Pubitemid 32625236)
3. Balady G J, Williams M A, Ades P A, Bittner V, Comoss P, Foody J A, Franklin B, Sanderson B, Southard D. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev: 2007; 27 121 129 (Pubitemid 47430525)
4. Bjarnason-Wehrens B, McGee H, Zwisler A D, Piepoli M F, Benzer W, Schmid J P, Dendale P, Pogosova N G, Zdrenghea D, Niebauer J, Mendes M. Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey. Eur J Cardiovasc Prev Rehabil: 2010; 17 410 418
5. Blake G J, Ridker P M. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med: 2002; 252 283 294 (Pubitemid 35253696)
6. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis: 2003; 170 191 203 (Pubitemid 37377790)
7. Caulin-Glaser T, Falko J, Hindman L, La Londe M, Snow R. Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease. J Cardiopulm Rehabil. 2005; 25 332 336 quiz 337-338
8. Constans J, Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta: 2006; 368 33 47 (Pubitemid 43792418)
9. Fichtlscherer S, Breuer S, Heeschen C, Dimmeler S, Zeiher A M. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol: 2004; 44 44 49 (Pubitemid 38968454)
10. Freedson P S, Melanson E, Sirard J. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc: 1998; 30 777 781 (Pubitemid 28211005)
11. Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol: 2005; 100 93 99 (Pubitemid 40487942)
12. Harriss D J, Atkinson G. Update - Ethical Standards in Sport and Exercise Science Research. Int J Sports Med: 2011; 32 819 821
13. Heeschen C, Dimmeler S, Hamm C W, Fichtlscherer S, Boersma E, Simoons M L, Zeiher A M. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation: 2003; 107 2109 2114 (Pubitemid 36532192)
14. Imhof A, Frohlich M, Loewel H, Helbecque N, Woodward M, Amouyel P, Lowe G D, Koenig W. Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem: 2003; 49 669 672 (Pubitemid 36379539)
15. Jolliffe J A, Rees K, Taylor R S, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev: 2001; CD001800
16. Kasapis C, Thompson P D. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol: 2005; 45 1563 1569 (Pubitemid 40704486)
17. Kushner I, Broder M L, Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest: 1978; 61 235 242 (Pubitemid 8280392)
18. Lichtenstein A H, Appel L J, Brands M, Carnethon M, Daniels S, Franch H A, Franklin B, Kris-Etherton P, Harris W S, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation: 2006; 114 82 96 (Pubitemid 44305278)
19. Lusis A J. Atherosclerosis. Nature: 2000; 407 233 241
20. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau M F, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ Res: 1999; 85 e17 e24
21. Milani R V, Lavie C J, Mehra M R. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol: 2004; 43 1056 1061 (Pubitemid 38352988)
22. Pluss C E, Karlsson M R, Wallen N H, Billing E, Held C. Effects of an expanded cardiac rehabilitation programme in patients treated for an acute myocardial infarction or a coronary artery by-pass graft operation. Clin Rehabil: 2008; 22 306 318 (Pubitemid 351676274)
23. Ribeiro F, Alves A J, Duarte J A, Oliveira J. Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int J Cardiol: 2010; 141 214 221
24. Saadeddin S M, Habbab M A, Sobki S H, Ferns G A. Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention. Am J Cardiol: 2002; 89 981 983 (Pubitemid 34310301)
25. Sixt S, Rastan A, Desch S, Sonnabend M, Schmidt A, Schuler G, Niebauer J. Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease. Eur J Cardiovasc Prev Rehabil: 2008; 15 473 478
26. Smith J K, Dykes R, Douglas J E, Krishnaswamy G, Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA: 1999; 281 1722 1727 (Pubitemid 29226483)
27. Smith S C, Anderson J L, Cannon R O, Fadl Y Y, Koenig W, Libby P, Lipshultz S E, Mensah Ga, Ridker P M, Rosenson R. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. Circulation: 2004; 110 E550 E553
28. Taylor R S, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone J A, Thompson D R, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med: 2004; 116 682 692 (Pubitemid 38581114)
29. Walther C, Mobius-Winkler S, Linke A, Bruegel M, Thiery J, Schuler G, Halbrecht R. Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil: 2008; 15 107 112 (Pubitemid 351263264)
30. Wegge J K, Roberts C K, Ngo T H, Barnard R J. Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease. Metabolism: 2004; 53 377 381 (Pubitemid 38684699)
31. Wu J T, Wu L L. Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment. Clin Chim Acta: 2006; 366 74 80 (Pubitemid 43330968)